• Contact Us
  • About
  • Advertise
  • Careers
Kashmir Dot Com
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us
No Result
View All Result
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us
No Result
View All Result
Kashmir Dot Com
No Result
View All Result
Home Health

Indian scientists find drugs with potential to treat neurodegenerative disorders

Kashmir Dot Com by Kashmir Dot Com
May 21, 2025
in Health
0
Indian scientists find drugs with potential to treat neurodegenerative disorders

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills. (Pic Via NIA Website) ( File Image )

0
SHARES
83
VIEWS
Share on Facebook

New Delhi, May 21:  A team of scientists at the Institute of Advanced Study in Science and Technology (IASST), an autonomous institute of the Department of Science and Technology (DST), has found drugs with potential to treat neurodegenerative disorders — a major global health challenge.

In the study, published in the Journal Drug Discovery Today, the team highlighted the potential of peptidomimetics to treat neurodegenerative diseases, like Alzheimer’s disease, Parkinson’s disease, by promoting neuronal growth and survival.

Peptidomimetic drugs — or synthetic molecules that mimic the structure of natural proteins — can be repurposed to provide an effective therapeutic strategy to treat neurodegenerative diseases by promoting neuronal growth and survival.

While neurotrophins, proteins crucial for neuronal survival and function, have shown promise as potential treatments, their instability and rapid degradation have hindered their therapeutic application.

IASST scientists have been exploring peptidomimetics, synthetic compounds designed to mimic neurotrophins, as a potential solution to these limitations.

“Neurotrophin peptidomimetics are developed to target specific biological functions and can be valuable tools in drug discovery, especially when natural peptides have limitations like poor oral bioavailability or susceptibility to degradation,” said the team led by Prof. Ashis K. Mukherjee.

“One of the significant advantages of peptidomimetics is their improved stability and bioavailability compared to endogenous neurotrophins. This means they can be delivered more effectively to the brain and maintain their therapeutic activity for a longer duration,” the team added.

In addition, peptidomimetics can be designed to be more specific to their target receptors, reducing the risk of side effects.

The research focused on understanding the signaling pathways involved in neuronal growth and survival, the potential pharmacological targets of peptidomimetics, and their therapeutic applications for neurodegenerative diseases.

The team also explored the possibility of repurposing existing peptidomimetic drugs for other diseases, such as cancer, and the potential for developing new drug prototypes based on neurotrophins mimetics.

As research progresses, the team said that peptidomimetics could become a key therapeutic strategy, offering new hope for managing and treating neurodegenerative disorders for future generations. (IANS)

Tags: neurodegenerative
Previous Post

National Conference Working Committee Meets To Discuss ‘Fallout Of Pahalgam Terror Attack’

Next Post

Live Shell Recovered from Vegetable Field in Budgam

Next Post
Live Shell Recovered from Vegetable Field in Budgam

Live Shell Recovered from Vegetable Field in Budgam

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

ADVERTISEMENT

LATEST NEWS

Centre Transfers Three IAS Officers from Delhi to Jammu and Kashmir

J&K SEC Shantmanu attends meeting with President at Rashtrapati Bhavan

Spl Secy Cabinet Secretariat reviews deregulation reforms with Chief Secretary Dr. Sajjan

IndiGo cancels Saudi Arabia flights till Nov 30

FDA Seals Hattrick’s Storage Area in Rajbagh Over Food Safety Violations; 69 Inspections Conducted Across J&K

JKSA Slams BGSBU VC Over Invitation to RSS Pracharak Indresh Kumar as Chief Guest, Seeks Probe

SMC Seals Unauthorised Car Washing Centre in Srinagar’s Natipora

NIT Srinagar selects three teams for National-Level Design for Bharat 2027 challenge

Article 21 means nothing but lip service if police fancy dictates preventive detention: J&K High Court

Only Handful of Foreign Terrorists Remain in J&K, UT Will Soon Be Terror-Free: LG Sinha

Facebook Twitter

About Us

Kashmir Dot Com (KDC) is J&K's premier News Agency having a vast reach of audience.

Kashmir Dot Com is a News Agency based in Srinagar, J&K that offers syndicated multimedia news feed to plethora of news-bureaus in J&K and beyond. We also provide a range of facilities from foreign and domestic channels to package their reports in Jammu and Kashmir. We cover almost all areas of interest in J&K to viewers including news, entertainment, and life styles, bussiness, sports, human-interest features and social and developmental issues.

KDC can well and truly take pride in the legacy of it's work, and in it's contribution towards the building of a free and fair Press in Jammu and Kashmir.

Category

  • Business
  • Entertainment
  • Health
  • JAMMU
  • Kashmir
  • Lead
  • National
  • Opinion
  • Politics
  • Science
  • Sports
  • Tech
  • Uncategorized
  • World

Company Info

  • Contact Us
  • About
  • Advertise
  • Careers

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.

error: Content is protected !!
No Result
View All Result
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.